Yoshihiro Kameoka

MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes

Mika Inomata, Hiroyuki Tagawa, Yong‐Mei Guo et al. · Blood · 2008 · 248 citations · Full text

Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer–cell lymphoma/leukemia

Yasuo Yamanaka, Hiroyuki Tagawa, Naoto Takahashi et al. · Blood · 2009 · 208 citations

The role of microRNA-150 as a tumor suppressor in malignant lymphoma

Atsushi Watanabe, Hitoshi Tagawa, Junsuke Yamashita et al. · Leukemia · 2011 · 172 citations

Tumor Biology, Lymphoid Neoplasia, Medicine +9

Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia

Naoto Takahashi, Masatomo Miura, Stuart A. Scott et al. · Journal of Human Genetics · 2010 · 162 citations · Full text

Hematological Malignancy, Oncology, Medicine +9

Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells

Atsushi Tanaka, Hiroyoshi Nishikawa, Shinsuke Noguchi et al. · The Journal of Experimental Medicine · 2019 · 91 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +21